Speculation about why Michelle Lee resigned as USPTO director, the IPO releasing its list of the top 300 organisations granted US patents, Federal Circuit arguments in Amgen and Sanofi’s dispute over cholesterol drug patents, a setback for Puma in its lawsuit against Forever 21, how TC Heartland will affect Section 101 rulings, and an affirmation of a $234m verdict against Apple were in the recent intellectual property news
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works